✦ LIBER ✦

Second-Line Chemotherapy Use in Metastatic Colon Cancer Varies by Disease Responsiveness

✍ Scribed by Seth Politano; Michael Overman; Priyanka Pathak; Romil Chadha; Katrina Glover; David Z. Chang; Robert A. Wolff; Paulo M. Hoff; James Abbruzzese; Cathy Eng; Scott Kopetz

Book ID: 119935129
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 113 KB
Volume: 7
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2008.n.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to docetaxel/carboplatin-based

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Successful and Well-Tolerated Second Lin

Successful and Well-Tolerated Second Line Therapy with Cetuximab, Irinotecan, and Raltitrexed in Progressive Liver Disease Due to Metastatic Colon Cancer

✍ F. Geurs; S. Vandewaeter; S. Ponette; J. Ponette; S. Knape; P. Demetter 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 161 KB

Glutathione concentration may be a usefu

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer

✍ Junzo Kigawa; Yukihisa Minagawa; Yasunobu Kanamori; Hiroaki Itamochi; Xiusi Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

in tumor samples was determined by immunohistochemical staining and Western blot analysis. GSH concentration was measured by an enzymatic assay. Department of Obstetrics and Gynecology, Tot- ## RESULTS. The response rate was 38.4%. The estimated 3-year survival rate for tori University School of

Detection of novel biomarkers by plasma

Detection of novel biomarkers by plasma proteomic profiling of oesophageal cancer mouse xenografts using three human cell lines in response to chemotherapy

✍ P. Kelly; V. Appleyard; K. Murray; F. Paulin; S. Fong; A. Thompson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

0187 Weekly docetaxel with or without ge

0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

✍ F. Zagouri; A. Bamias; P. Papakostas; A. Karadimou; E. Bournakis; M. Dimopoulos; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB